盐酸乌拉地尔结构式
|
常用名 | 盐酸乌拉地尔 | 英文名 | Urapidil Hydrochloride |
|---|---|---|---|---|
| CAS号 | 64887-14-5 | 分子量 | 423.937 | |
| 密度 | N/A | 沸点 | 549ºC at 760 mmHg | |
| 分子式 | C20H30ClN5O3 | 熔点 | 156-158ºC | |
| MSDS | 中文版 美版 | 闪点 | 285.8ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
盐酸乌拉地尔用途Urapidil盐酸盐是α1-肾上腺素受体拮抗剂和5-HT1A受体激动剂。 |
| 中文名 | 盐酸乌拉地尔 |
|---|---|
| 英文名 | Urapidil Hydrochloride |
| 英文别名 | 更多 |
| 描述 | Urapidil盐酸盐是α1-肾上腺素受体拮抗剂和5-HT1A受体激动剂。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 沸点 | 549ºC at 760 mmHg |
|---|---|
| 熔点 | 156-158ºC |
| 分子式 | C20H30ClN5O3 |
| 分子量 | 423.937 |
| 闪点 | 285.8ºC |
| 精确质量 | 423.203705 |
| PSA | 71.74000 |
| LogP | 1.59470 |
| InChIKey | KTMLZVUAXJERAT-UHFFFAOYSA-N |
| SMILES | COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1.Cl |
| 外观性状 | 白色或灰白色结晶粉末 |
| 储存条件 | Desiccate at RT |
| 水溶解性 | H2O: soluble |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
| 危害码 (欧洲) | Xn:Harmful; |
| 风险声明 (欧洲) | R22 |
| 安全声明 (欧洲) | S36 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
| RTECS号 | YQ9862000 |
| 海关编码 | 3004909090 |
| 海关编码 | 3004909090 |
|---|
|
Facilitation of expulsion of ureteral stones by addition of α1-blockers to conservative therapy.
Scand. J. Urol. Nephrol. 44(6) , 420-4, (2010) An antispasmodic agent and a medicine that facilitates stone expulsion are given commonly as conservative therapy for ureteral stones in Japan. The goal of this study was to compare the efficacy of th... |
|
|
Capillary electrophoresis with end-column electrochemiluminescence for ultrasensitive determination of urapidil hydrochloride in rat plasma and its application to pharmacokinetics study.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 1006 , 146-50, (2015) A simple, sensitive and selective method for determination of urapidil hydrochloride was developed using capillary electrophoresis with electrochemiluminescence (CE-ECL) technique for the first time. ... |
|
|
[Hypertensive crisis in cardiology: place of urapidil].
Kardiologiia 52(1) , 86-90, (2012)
|
| 2,4(1H,3H)-Pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-, monohydrochloride |
| 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione,hydrochloride |
| 6-({3-[4-(2-Methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione hydrochloride (1:1) |
| 2,4(1H,3H)-Pyrimidinedione, 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-, hydrochloride (1:1) |
| 6-({3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl}amino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione hydrochloride (1:1) |